June 2026 Abbott expanded its diabetes care ecosystem by extending its strategic collaboration with Medtronic to commercialize dual glucose-ketone sensing technology integrated with MiniMed automated insulin delivery systems. The partnership strengthens next-generation diabetes device offerings that are expected to benefit markets across Latin America.
June 2025 Tandem Diabetes Care entered a strategic partnership with Abbott to integrate Abbott's under-development dual glucose-ketone sensor with Tandem's insulin delivery systems, expanding connected diabetes management solutions and enhancing interoperability between continuous glucose monitoring and insulin pump technologies.